 Altimmune Inc NASDAQ:ALT is already taking its place as one of the worst performing stocks on the Nasdaq today, down 30.8 at 11 this morning, following news that the company dropped the development of its nasal Covid-19 vaccine after an early stage trial exhibited immune responses that missed expectations. 